금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
CPI Inflation Overshoots, Putting Fed Hike In Play; S&P 500 Futures Fall, Yields Jump (Live Coverage)
September core CPI inflation rose more than expected, keeping an October Fed rate hike in play. Trea...
CPI Inflation Data To Set Stage For Next Fed Meeting (Live Coverage)
Core CPI inflation is forecast to edge up to 2.5%....
Dow Jones recovering? Four keys to watch, Nasdaq at resistance, US CPI in focus today
Thanks to the high price of crude and the threat of interest rate rises by the Fed, the Dow Jones In...
Newmont’s rally is running hot: Stock gains 12% in one week; more upside ahead?
CrowdStrike Stock's Surge Showed Up In Its Bookings Two Reports Early
The demand behind the run was already in its subscription commitments two reports before the price moved.
M&T Bank Rallies Nearly 20% in 3 Months: Hold or Fold the Stock Now?
Can MTB's strong revenue growth, acquisitions and capital returns sustain its momentum after a 20.3% three-month gain? Let us discuss.
Rapid7 rallies over 17% after healthy Q2 print, announces 12% headcount reduction
Moscow releases former US Marine after four-year stint in Russian prison
State department says American was freed without prisoner exchange or Washington concessions
Japanese Yen pares losses ahead of US inflation report
The Japanese Yen (JPY) trades flat above 159.00 on Tuesday after several days of US Dollar (USD) strength following the intervention that briefly boosted the Yen. The pair has retraced most of its sha ...
Helios expects $880M-$900M 2026 sales and $3.05-$3.25 adjusted EPS as it raises outlook
Sector Update: Energy Stocks Gain Tuesday Afternoon
Energy stocks were higher Tuesday afternoon, with the NYSE Energy Sector Index rising 0.7% and the S
Harvard Bioscience targets 3% to 5% full-year 2026 revenue growth as CMT and China mix shifts gross margin to 57% to 59%
Janus outlines 2026 revenue of $925M-$945M and adjusted EBITDA of $150M-$170M amid muted demand
Ton Strategy outlines $4M-$5M annual OpEx reduction with majority of savings expected in Q4
Intensity therapeutics targets INVINCIBLE-4 enrollment completion by end of 2027 while seeking $30M to finish INVINCIBLE-3